Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for UCB Societe Anonyme v. Mylan Laboratories (N.D. Ga. )

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in UCB Societe Anonyme v. Mylan Laboratories
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for UCB Societe Anonyme v. Mylan Laboratories (N.D. Ga. )

Date Filed Document No. Description Snippet Link To Document
2006-02-28 156 UCB holds U.S. Patent Nos. 4,837,223 (the “‘223 patent”) and 4,943,639 (the “‘639 patent”) for this drug…for a patent-infringement action before the ANDA drug has been marketed to determine if the patent is valid…generic drug would infringe the patent. An ANDA applicant must address patents covering the drug by filing…Claims [112]. I. BACKGROUND These are patent infringement actions involving UCB Societe Anonyme…as part of their ANDA, Defendants claim UCB’s patents are invalid and will not be infringed by the generic External link to document
2006-03-02 157 UCB holds U.S. Patent Nos. 4,837,223 (the “‘223 patent”) and 4,943,639 (the “‘639 patent”) for this drug… regarding the United States Patent and Trademark Office’s (“Patent Office”) practices and procedures…experience working in the Patent Office, and he served as an Administrative Patent Judge. The Court’s independent…: • Patent Office procedures and policies; • The patent applicant’s duty of…candor to the Patent Office; and • The prosecution histories of the patents-in-suit. (Goolkasian External link to document
2006-06-14 211 construction of a claim in United States Patent No. 4,943,639 (the “‘639 patent”). Each party has submitted memoranda…United States Patent No. 4,836,223 (“the ‘223 patent), which is related to the ‘639 patent. See Elkay Mfg…history of a patent contains the complete record of the proceedings before the United States Patent and Trademark…limitation in any patent that has issued applies with equal force to subsequently issued patents that contain….” (‘639 patent, col. 10, ll. 18-20.)5 The term “substantially” is commonly used in patents. “[W]ords External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.